SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.08-2.7%Nov 14 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Brander who wrote (7768)6/1/1999 11:03:00 AM
From: DaiS  Read Replies (1) of 9523
 
Brander.....or anyone

I notice that Pfizer have a patent for use of SSRIs for treating PE dating in early 1990s and I also found two journal publications by Pfizer on this use.

Do you know the current state of play regarding exploitation by Pfizer of SSRIs for treating PE. Pentech Pharmaceuticals also have phase II trials in progress testing SSRIs for PE and have patents in this area.

How could a company like Pfizer exploit this use commercially? Are they doing so? If they are not, does this relate to ...... the perceived side effects of SSRIs, or to rights issues or what....?

DaiS

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext